ANI Pharmaceuticals
ANIP
ANIP
126 hedge funds and large institutions have $259M invested in ANI Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 52 increasing their positions, 44 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
37% less capital invested
Capital invested by funds: $413M → $259M (-$154M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
66% less call options, than puts
Call options by funds: $707K | Put options by funds: $2.09M
Holders
126
Holding in Top 10
1
Calls
$707K
Puts
$2.09M
Top Buyers
| 1 | +$7.62M | |
| 2 | +$5.9M | |
| 3 | +$4.69M | |
| 4 |
TSW
Thompson Siegel & Walmsley
Richmond,
Virginia
|
+$4.06M |
| 5 |
William Blair Investment Management
Chicago,
Illinois
|
+$3.37M |
Top Sellers
| 1 | -$14.2M | |
| 2 | -$5.62M | |
| 3 | -$4.47M | |
| 4 |
KCM
Kingdon Capital Management
New York
|
-$3M |
| 5 |
WC
Walthausen & Co
Malta,
New York
|
-$2.83M |